Zobrazeno 1 - 10
of 84
pro vyhledávání: '"T. Riauka"'
Autor:
A.G. Abraham, T. Riauka, M. Hudson, S. Ghosh, S. Zebak, V. Alba, E. Vaihenberg, H. Warkentin, K. Tankel, D. Severin, E. Bedard, J. Spratlin, K. Mulder, K. Joseph
Publikováno v:
Clinical Oncology. 35:177-187
Publikováno v:
EJNMMI Physics
EJNMMI Physics, Vol 6, Iss 1, Pp 1-14 (2019)
EJNMMI Physics, Vol 6, Iss 1, Pp 1-14 (2019)
Purpose The decay characteristics of radionuclides in PET studies can impact image reconstruction. 44gSc has been the topic of recent research due to potential theranostic applications and is a promising radiometal for PET imaging. In this study, the
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e664-e665
Autor:
Keith Tankel, S. Koumna, K.P. Sanghera, Zsolt Gabos, E. Hudson, Susan Chafe, T. Riauka, Matthew Parliament, F. Gheisari, Bassam Abdulkarim, Kurian Joseph
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e21-e22
Autor:
Keith Tankel, Emmanuel Hudson, Stella Koumna, Bassam Abdulkarim, Zsolt Gabos, Susan Chafe, Karan Paul Sanghera, Farshid Gheisari, T. Riauka, Matthew Parliament, Kurian Joseph
Publikováno v:
Radiotherapy and Oncology. 150:S23-S24
Autor:
Keith Tankel, Robert MacEwan, Tirath Nijjar, Diane Severin, C.M. Doll, Nawaid Usmani, T. Riauka, Heather Warkentin, Sunita Ghosh, Dan Schiller, Karen E. Mulder, Kurian Joseph, Clarence Wong, Yugmel Nijjar, Adele Duimering, Alysa Fairchild
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 136
Background and purpose We prospectively assessed the contributions of PET to initial staging, early detection of treatment failures, and prognostication in patients with anal squamous cell carcinoma (ASCC). Materials and methods Consecutive patients
Autor:
T. Riauka, Sunita Ghosh, Emmanuel Hudson, Kurian Joseph, Aswin George Abraham, Corinne M. Doll, Che Hsuan David Wu
Publikováno v:
Radiotherapy and Oncology. 150:S60
Publikováno v:
Clinical nuclear medicine. 42(5)
Systemic radioisotope therapy with I-metaiodobenzylguanidine (I-MIBG) is an effective form of targeted therapy for neuroendocrine tumors. One of the absolute contraindications to administering I-MIBG therapy listed in the 2008 European Association of
Publikováno v:
AIP Conference Proceedings.
There is a wide diversity of production methods for radionuclides. With these, intensive calculations are often required to characterize the different radionuclide production strategies and to determine optimal irradiation parameters. These calculati
Publikováno v:
Nuclear Medicine and Biology. :S35